Novo Nordisk Says Ozempic Drug Cuts Risk of Kidney Problems

Novo Nordisk’s blockbuster weight-loss drug cuts the risk of kidney disease-related events in diabetic patients by 24%, according to a new clinical trial conducted by the company.#novonordisks
Source: Reuters: Health - Category: Consumer Health News Source Type: news